1 Supply Summary

• 1.1 Enoxaparin Sodium Introduction
• 1.2 World Enoxaparin Sodium Supply & Forecast
  • 1.2.1 World Enoxaparin Sodium Production Value (2021 & 2025 & 2032)
  • 1.2.2 World Enoxaparin Sodium Production (2021-2032)
  • 1.2.3 World Enoxaparin Sodium Pricing Trends (2021-2032)
• 1.3 World Enoxaparin Sodium Production by Region (Based on Production Site)
  • 1.3.1 World Enoxaparin Sodium Production Value by Region (2021-2032)
  • 1.3.2 World Enoxaparin Sodium Production by Region (2021-2032)
  • 1.3.3 World Enoxaparin Sodium Average Price by Region (2021-2032)
  • 1.3.4 North America Enoxaparin Sodium Production (2021-2032)
  • 1.3.5 Europe Enoxaparin Sodium Production (2021-2032)
  • 1.3.6 Southeast Asia Enoxaparin Sodium Production (2021-2032)
  • 1.3.7 Israel Enoxaparin Sodium Production (2021-2032)
  • 1.3.8 China Enoxaparin Sodium Production (2021-2032)
  • 1.3.9 India Enoxaparin Sodium Production (2021-2032)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Enoxaparin Sodium Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Enoxaparin Sodium Major Market Trends

2 Demand Summary

• 2.1 World Enoxaparin Sodium Demand (2021-2032)
• 2.2 World Enoxaparin Sodium Consumption by Region
  • 2.2.1 World Enoxaparin Sodium Consumption by Region (2021-2026)
  • 2.2.2 World Enoxaparin Sodium Consumption Forecast by Region (2027-2032)
• 2.3 United States Enoxaparin Sodium Consumption (2021-2032)
• 2.4 China Enoxaparin Sodium Consumption (2021-2032)
• 2.5 Europe Enoxaparin Sodium Consumption (2021-2032)
• 2.6 Japan Enoxaparin Sodium Consumption (2021-2032)
• 2.7 South Korea Enoxaparin Sodium Consumption (2021-2032)
• 2.8 ASEAN Enoxaparin Sodium Consumption (2021-2032)
• 2.9 India Enoxaparin Sodium Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

• 3.1 World Enoxaparin Sodium Production Value by Manufacturer (2021-2026)
• 3.2 World Enoxaparin Sodium Production by Manufacturer (2021-2026)
• 3.3 World Enoxaparin Sodium Average Price by Manufacturer (2021-2026)
• 3.4 Enoxaparin Sodium Company Evaluation Quadrant
• 3.5 Industry Rank and Concentration Rate (CR)
  • 3.5.1 Global Enoxaparin Sodium Industry Rank of Major Manufacturers
  • 3.5.2 Global Concentration Ratios (CR4) for Enoxaparin Sodium in 2025
  • 3.5.3 Global Concentration Ratios (CR8) for Enoxaparin Sodium in 2025
• 3.6 Enoxaparin Sodium Market: Overall Company Footprint Analysis
  • 3.6.1 Enoxaparin Sodium Market: Region Footprint
  • 3.6.2 Enoxaparin Sodium Market: Company Product Type Footprint
  • 3.6.3 Enoxaparin Sodium Market: Company Product Application Footprint
• 3.7 Competitive Environment
  • 3.7.1 Historical Structure of the Industry
  • 3.7.2 Barriers of Market Entry
  • 3.7.3 Factors of Competition
• 3.8 New Entrant and Capacity Expansion Plans
• 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

• 4.1 United States VS China: Enoxaparin Sodium Production Value Comparison
  • 4.1.1 United States VS China: Enoxaparin Sodium Production Value Comparison (2021 & 2025 & 2032)
  • 4.1.2 United States VS China: Enoxaparin Sodium Production Value Market Share Comparison (2021 & 2025 & 2032)
• 4.2 United States VS China: Enoxaparin Sodium Production Comparison
  • 4.2.1 United States VS China: Enoxaparin Sodium Production Comparison (2021 & 2025 & 2032)
  • 4.2.2 United States VS China: Enoxaparin Sodium Production Market Share Comparison (2021 & 2025 & 2032)
• 4.3 United States VS China: Enoxaparin Sodium Consumption Comparison
  • 4.3.1 United States VS China: Enoxaparin Sodium Consumption Comparison (2021 & 2025 & 2032)
  • 4.3.2 United States VS China: Enoxaparin Sodium Consumption Market Share Comparison (2021 & 2025 & 2032)
• 4.4 United States Based Enoxaparin Sodium Manufacturers and Market Share, 2021-2026
  • 4.4.1 United States Based Enoxaparin Sodium Manufacturers, Headquarters and Production Site (States, Country)
  • 4.4.2 United States Based Manufacturers Enoxaparin Sodium Production Value (2021-2026)
  • 4.4.3 United States Based Manufacturers Enoxaparin Sodium Production (2021-2026)
• 4.5 China Based Enoxaparin Sodium Manufacturers and Market Share
  • 4.5.1 China Based Enoxaparin Sodium Manufacturers, Headquarters and Production Site (Province, Country)
  • 4.5.2 China Based Manufacturers Enoxaparin Sodium Production Value (2021-2026)
  • 4.5.3 China Based Manufacturers Enoxaparin Sodium Production (2021-2026)
• 4.6 Rest of World Based Enoxaparin Sodium Manufacturers and Market Share, 2021-2026
  • 4.6.1 Rest of World Based Enoxaparin Sodium Manufacturers, Headquarters and Production Site (State, Country)
  • 4.6.2 Rest of World Based Manufacturers Enoxaparin Sodium Production Value (2021-2026)
  • 4.6.3 Rest of World Based Manufacturers Enoxaparin Sodium Production (2021-2026)

5 Market Analysis by Type

• 5.1 World Enoxaparin Sodium Market Size Overview by Type: 2021 VS 2025 VS 2032
• 5.2 Segment Introduction by Type
  • 5.2.1 20 mg/0.2mL
  • 5.2.2 30 mg/0.3mL
  • 5.2.3 40 mg/0.4mL
  • 5.2.4 60 mg/0.6mL
  • 5.2.5 80 mg/0.8mL
  • 5.2.6 100 mg/1mL
  • 5.2.7 120 mg/0.8mL
  • 5.2.8 150 mg/1mL
  • 5.2.9 300mg/3mL
• 5.3 Market Segment by Type
  • 5.3.1 World Enoxaparin Sodium Production by Type (2021-2032)
  • 5.3.2 World Enoxaparin Sodium Production Value by Type (2021-2032)
  • 5.3.3 World Enoxaparin Sodium Average Price by Type (2021-2032)

6 Market Analysis by Sales Channel

• 6.1 World Enoxaparin Sodium Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
• 6.2 Segment Introduction by Sales Channel
  • 6.2.1 Hospital & Clinic
  • 6.2.2 Pharmacy
  • 6.2.3 Others
• 6.3 Market Segment by Sales Channel
  • 6.3.1 World Enoxaparin Sodium Production by Sales Channel (2021-2032)
  • 6.3.2 World Enoxaparin Sodium Production Value by Sales Channel (2021-2032)
  • 6.3.3 World Enoxaparin Sodium Average Price by Sales Channel (2021-2032)

7 Company Profiles

• 7.1 Sanofi
  • 7.1.1 Sanofi Details
  • 7.1.2 Sanofi Major Business
  • 7.1.3 Sanofi Enoxaparin Sodium Product and Services
  • 7.1.4 Sanofi Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.1.5 Sanofi Recent Developments/Updates
  • 7.1.6 Sanofi Competitive Strengths & Weaknesses
• 7.2 Techdow (Hepalink)
  • 7.2.1 Techdow (Hepalink) Details
  • 7.2.2 Techdow (Hepalink) Major Business
  • 7.2.3 Techdow (Hepalink) Enoxaparin Sodium Product and Services
  • 7.2.4 Techdow (Hepalink) Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.2.5 Techdow (Hepalink) Recent Developments/Updates
  • 7.2.6 Techdow (Hepalink) Competitive Strengths & Weaknesses
• 7.3 Teva
  • 7.3.1 Teva Details
  • 7.3.2 Teva Major Business
  • 7.3.3 Teva Enoxaparin Sodium Product and Services
  • 7.3.4 Teva Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.3.5 Teva Recent Developments/Updates
  • 7.3.6 Teva Competitive Strengths & Weaknesses
• 7.4 Nanjing King-friend
  • 7.4.1 Nanjing King-friend Details
  • 7.4.2 Nanjing King-friend Major Business
  • 7.4.3 Nanjing King-friend Enoxaparin Sodium Product and Services
  • 7.4.4 Nanjing King-friend Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.4.5 Nanjing King-friend Recent Developments/Updates
  • 7.4.6 Nanjing King-friend Competitive Strengths & Weaknesses
• 7.5 Rovi
  • 7.5.1 Rovi Details
  • 7.5.2 Rovi Major Business
  • 7.5.3 Rovi Enoxaparin Sodium Product and Services
  • 7.5.4 Rovi Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.5.5 Rovi Recent Developments/Updates
  • 7.5.6 Rovi Competitive Strengths & Weaknesses
• 7.6 Fresenius Kabi
  • 7.6.1 Fresenius Kabi Details
  • 7.6.2 Fresenius Kabi Major Business
  • 7.6.3 Fresenius Kabi Enoxaparin Sodium Product and Services
  • 7.6.4 Fresenius Kabi Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.6.5 Fresenius Kabi Recent Developments/Updates
  • 7.6.6 Fresenius Kabi Competitive Strengths & Weaknesses
• 7.7 Fosun Pharma(Gland Pharma)
  • 7.7.1 Fosun Pharma(Gland Pharma) Details
  • 7.7.2 Fosun Pharma(Gland Pharma) Major Business
  • 7.7.3 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Product and Services
  • 7.7.4 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.7.5 Fosun Pharma(Gland Pharma) Recent Developments/Updates
  • 7.7.6 Fosun Pharma(Gland Pharma) Competitive Strengths & Weaknesses
• 7.8 Amphastar
  • 7.8.1 Amphastar Details
  • 7.8.2 Amphastar Major Business
  • 7.8.3 Amphastar Enoxaparin Sodium Product and Services
  • 7.8.4 Amphastar Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.8.5 Amphastar Recent Developments/Updates
  • 7.8.6 Amphastar Competitive Strengths & Weaknesses
• 7.9 Sandoz (Novartis)
  • 7.9.1 Sandoz (Novartis) Details
  • 7.9.2 Sandoz (Novartis) Major Business
  • 7.9.3 Sandoz (Novartis) Enoxaparin Sodium Product and Services
  • 7.9.4 Sandoz (Novartis) Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.9.5 Sandoz (Novartis) Recent Developments/Updates
  • 7.9.6 Sandoz (Novartis) Competitive Strengths & Weaknesses
• 7.10 Apotex
  • 7.10.1 Apotex Details
  • 7.10.2 Apotex Major Business
  • 7.10.3 Apotex Enoxaparin Sodium Product and Services
  • 7.10.4 Apotex Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.10.5 Apotex Recent Developments/Updates
  • 7.10.6 Apotex Competitive Strengths & Weaknesses
• 7.11 Huadong Medicine
  • 7.11.1 Huadong Medicine Details
  • 7.11.2 Huadong Medicine Major Business
  • 7.11.3 Huadong Medicine Enoxaparin Sodium Product and Services
  • 7.11.4 Huadong Medicine Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.11.5 Huadong Medicine Recent Developments/Updates
  • 7.11.6 Huadong Medicine Competitive Strengths & Weaknesses
• 7.12 Cipla
  • 7.12.1 Cipla Details
  • 7.12.2 Cipla Major Business
  • 7.12.3 Cipla Enoxaparin Sodium Product and Services
  • 7.12.4 Cipla Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.12.5 Cipla Recent Developments/Updates
  • 7.12.6 Cipla Competitive Strengths & Weaknesses
• 7.13 Taj Pharma
  • 7.13.1 Taj Pharma Details
  • 7.13.2 Taj Pharma Major Business
  • 7.13.3 Taj Pharma Enoxaparin Sodium Product and Services
  • 7.13.4 Taj Pharma Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.13.5 Taj Pharma Recent Developments/Updates
  • 7.13.6 Taj Pharma Competitive Strengths & Weaknesses
• 7.14 Chengdu Baiyu Pharmaceutical
  • 7.14.1 Chengdu Baiyu Pharmaceutical Details
  • 7.14.2 Chengdu Baiyu Pharmaceutical Major Business
  • 7.14.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product and Services
  • 7.14.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.14.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
  • 7.14.6 Chengdu Baiyu Pharmaceutical Competitive Strengths & Weaknesses
• 7.15 Changzhou Qianhong Bio-pharma
  • 7.15.1 Changzhou Qianhong Bio-pharma Details
  • 7.15.2 Changzhou Qianhong Bio-pharma Major Business
  • 7.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product and Services
  • 7.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
  • 7.15.6 Changzhou Qianhong Bio-pharma Competitive Strengths & Weaknesses
• 7.16 Beijing SL Pharmaceutical
  • 7.16.1 Beijing SL Pharmaceutical Details
  • 7.16.2 Beijing SL Pharmaceutical Major Business
  • 7.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Product and Services
  • 7.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.16.5 Beijing SL Pharmaceutical Recent Developments/Updates
  • 7.16.6 Beijing SL Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Enoxaparin Sodium Industry Chain
• 8.2 Enoxaparin Sodium Upstream Analysis
  • 8.2.1 Enoxaparin Sodium Core Raw Materials
  • 8.2.2 Main Manufacturers of Enoxaparin Sodium Core Raw Materials
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis
• 8.5 Enoxaparin Sodium Production Mode
• 8.6 Enoxaparin Sodium Procurement Model
• 8.7 Enoxaparin Sodium Industry Sales Model and Sales Channels
  • 8.7.1 Enoxaparin Sodium Sales Model
  • 8.7.2 Enoxaparin Sodium Typical Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Enoxaparin Sodium market size is expected to reach $ 6251 million by 2032, rising at a market growth of 7.0% CAGR during the forecast period (2026-2032).
Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.
Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.
In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.
This report studies the global Enoxaparin Sodium production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Enoxaparin Sodium and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Enoxaparin Sodium that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Enoxaparin Sodium total production and demand, 2021-2032, (M Units)
Global Enoxaparin Sodium total production value, 2021-2032, (USD Million)
Global Enoxaparin Sodium production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Enoxaparin Sodium consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Enoxaparin Sodium domestic production, consumption, key domestic manufacturers and share
Global Enoxaparin Sodium production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Enoxaparin Sodium production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Enoxaparin Sodium production by Sales Channel, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Enoxaparin Sodium market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, Sandoz (Novartis), Apotex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Enoxaparin Sodium market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channel. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Enoxaparin Sodium Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Enoxaparin Sodium Market, Segmentation by Type:
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Global Enoxaparin Sodium Market, Segmentation by Sales Channel:
Hospital & Clinic
Pharmacy
Others
Companies Profiled:
Sanofi
Techdow (Hepalink)
Teva
Nanjing King-friend
Rovi
Fresenius Kabi
Fosun Pharma(Gland Pharma)
Amphastar
Sandoz (Novartis)
Apotex
Huadong Medicine
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Key Questions Answered:
1. How big is the global Enoxaparin Sodium market?
2. What is the demand of the global Enoxaparin Sodium market?
3. What is the year over year growth of the global Enoxaparin Sodium market?
4. What is the production and production value of the global Enoxaparin Sodium market?
5. Who are the key producers in the global Enoxaparin Sodium market?
6. What are the growth factors driving the market demand?